| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.15.9.1412 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/full/10.1161/01.ATV.15.9.1412 |
| P698 | PubMed publication ID | 7670956 |
| P2093 | author name string | S. Wu | |
| Y. Huang | |||
| G. Assmann | |||
| A. von Eckardstein | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells | Q24336518 | ||
| Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 | ||
| Biochimica et Biophysica Acta | Q864239 | ||
| Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie | Q27711479 | ||
| Plasma high density lipoproteins. Metabolism and relationship to atherogenesis | Q34257420 | ||
| Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice | Q35824669 | ||
| High-density lipoprotein--the clinical implications of recent studies | Q38700033 | ||
| Cholesterol transport between cells and body fluids. Role of plasma lipoproteins and the plasma cholesterol esterification system. | Q40328388 | ||
| Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux | Q41578878 | ||
| Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters | Q42809345 | ||
| Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. | Q45932953 | ||
| Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol | Q46123307 | ||
| Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasma | Q46268227 | ||
| Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors | Q46492004 | ||
| Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. | Q46734243 | ||
| Characterization of human high-density lipoprotein subclasses LP A-I and LP A-I/A-II and binding to HepG2 cells | Q49170585 | ||
| Characterization of apolipoprotein A-containing lipoproteins. | Q51635301 | ||
| Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells. | Q53745027 | ||
| Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein | Q59070155 | ||
| Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase | Q67571184 | ||
| Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles | Q70164761 | ||
| Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease) | Q70372892 | ||
| Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein | Q70380516 | ||
| Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency | Q70489738 | ||
| Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations | Q71715710 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1412-1418 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma | |
| Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma | |||
| P478 | volume | 15 |
| Q37211146 | ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias |
| Q43545483 | Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion |
| Q37479758 | Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease |
| Q34740994 | Apolipoprotein A-II, HDL metabolism and atherosclerosis |
| Q42791504 | Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism? |
| Q35609905 | Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. |
| Q74567612 | Apolipoprotein-mediated cellular cholesterol efflux |
| Q33704372 | Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis |
| Q73284545 | Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein |
| Q37311118 | Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome |
| Q28586230 | Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility |
| Q43566935 | Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation |
| Q34558799 | Dynamics of reverse cholesterol transport: protection against atherosclerosis |
| Q38293462 | Dysfunctional HDL: from structure-function-relationships to biomarkers |
| Q73359069 | Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins |
| Q24323992 | HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway |
| Q73486403 | High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase |
| Q36903963 | Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits |
| Q78476856 | In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II |
| Q37176675 | Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. |
| Q51551450 | Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment. |
| Q34271942 | Raising HDL cholesterol in women. |
| Q37400800 | Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome. |
| Q38013180 | Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. |
| Q41006869 | Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture |
| Q33745525 | Speciated Human High-Density Lipoprotein Protein Proximity Profiles |
| Q73775753 | The genetic background modifies the effects of the obesity mutation, 'fatty', on apolipoprotein gene regulation in rat liver |
| Q44272957 | Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux |
Search more.